Heritage Group has exited Workpath, a developer of in-home care management software, through an acquisition by Ro.

Amgen is a shareholder of Vigil Neuroscience, which is developing microglia-based treatments for neurodegenerative diseases.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Kaiser Foundation Hospitals helped anti-ageing therapy developer BioAge Labs increase its overall funding to $137m.

Lilly Asia Ventures contributed to a round for the diabetes device developer that was co-led by Tencent, Beijing Taikang Investment Management and IDG Capital.

The Virginia Tech-allied brain injury diagnosis software company attracted Virginia Tech Carilion Innovation Fund in what appears to be its first round of funding.

SK Holdings has entered a strategic partnership with the pharmaceutical company builder as the latter unveils a new targeted protein degradation platform.

Asahi Intecc, Dai-Dan, StemCell Institute and Taiko Pharmaceutical all took part in a $19.3m round for the cell-derived heart therapy developer.

Spinout Space has secured a $250,000 grant from Bank of America Charitable Foundation to incubate nascent WSU life science projects.

Returning investor Tigermed helped the cancer and rare disease therapy developer close a round that will support commercialisation of its Hunter syndrome drug.